Delivery Order SPE2DB22D3004-SPE2DB23FQT51
Award Date 7/19/23
Potential Completion Date 7/20/23
Potential Value $417
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- Defense Logistics Agency Troop Support Medical awarded a $3,110.63 firm fixed price delivery order to Amerisourcebergen Drug Corporation for EMGALITY 120 MG/ML PENML. The delivery order was awarded on October 20, 2023 under the corporate vendor's blanket purchase agreement and has an anticipated completion date of October 23, 2023. The place of performance will be Amerisourcebergen's facility located in Conshohocken, Pennsylvania. No set-aside designation was applied to this delivery order for...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $4,627.12 to AmerisourceBergen Drug Corp for EMGALITY 120 mg/ml pen medication, effective December 10, 2025, with an ultimate completion date of December 11, 2025. This competitively awarded, firm fixed-price delivery order was placed against AmerisourceBergen's Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The place of performance...
- The Defense Logistics Agency awarded a $1,583.40 firm fixed-price delivery order to AmerisourceBergen Drug Corp for EMGALITY 120 mg/mL pen/milliliter on September 3, 2025, with an ultimate completion date of September 4, 2025. This award represents a non-competitive delivery order issued under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), which is valued at $999,999,999.00 and extends through December 2026. EMGALITY is a migraine treatment...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide EMGALITY 120 MG/ML PENML pharmaceutical products. The order has a potential value of $1,018.15 and a completion date of January 19, 2024. No set-aside designation was used for this award. Amerisourcebergen Drug Corp is a prime contractor that has received multiple federal contracts from DLA Troop...
- The Defense Logistics Agency awarded a $417 firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 120 MG/ML EMGALITY pens. Performance will occur in Conshohocken, Pennsylvania, with no set-aside designation specified. This order is likely associated with DLA's pharmaceutical prime vendor program, through which it acquires prescription drugs and related medical supplies for the Military Health System and other DoD...
- The Defense Logistics Agency awarded a delivery order valued at $1,114.74 to AmerisourceBergen Drug Corp for EMGALITY 120 mg/mL pen injectors, with an ultimate completion date of August 27, 2025. This non-competitive delivery order is issued under a firm fixed price arrangement and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award represents a continuation of AmerisourceBergen's role as a critical pharmaceutical supplier to the federal government,...
- The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $556.36 to Amerisourcebergen Drug Corporation. Under the contract, Amerisourcebergen will supply 120mg/ml Emgality pens to support the Department of Defense. Performance will occur at Amerisourcebergen's facility in Conshohocken, Pennsylvania over a one-day period in late August 2023. The Defense Logistics Agency leverages strategic sourcing vehicles to efficiently acquire pharmaceuticals and medical supplies for...
- The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $278.18 to Amerisourcebergen Drug Corporation. Under the contract, Amerisourcebergen will supply 120mg/ml Emgality pens to support the Department of Defense. Performance will occur at Amerisourcebergen's facility in Conshohocken, Pennsylvania over a one-day period in late August 2023. The Defense Logistics Agency leverages strategic sourcing vehicles to efficiently meet the medical supply needs of the military...
- The Defense Logistics Agency awarded a firm fixed price delivery order valued at approximately $139,000 to Amerisourcebergen Drug Corporation, a division of Amerisourcebergen Corporation. The order is for 120 mg/ml Emgality pens and will be fulfilled by Amerisourcebergen's Conshohocken, Pennsylvania facility between July 10-11, 2023. No set aside designation or subcontractors were indicated. The Defense Logistics Agency routinely issues such orders under its Prime Vendor program to support the...
- The Defense Logistics Agency awarded a $4,116.30 firm fixed price delivery order to AmerisourceBergen Drug Corp for EMGALITY 120 mg/ml pen medication, with performance in Conshohocken, Pennsylvania. The award was made on December 4, 2025, with an ultimate completion date of December 5, 2025, and was not designated as a set-aside contract. This delivery order represents a single transactional purchase under AmerisourceBergen's broader federal pharmaceutical supply agreements. This award is a...